Business Context and Reporting Period
This Form 8-K Current Report was filed by Landec Corporation on December 6, 2006, regarding events occurring on December 1, 2006. The filing details the divestiture of the company's row-crop seed business and the entry into a strategic technology licensing agreement with Monsanto Company.
Key Financial Metrics and Transaction Values
- Asset Sale Proceeds: Landec Ag, Inc. received an immediate payment of $50,000,000 from American Seeds, Inc. (a subsidiary of Monsanto) for the sale of FCD Holding Company.
- Potential Earn-Out: An additional $5,000,000 is contingent upon FCD meeting specific gross margin targets between June 1, 2006, and May 31, 2007.
- Licensing Revenue: Monsanto agreed to pay $12,500,000 over five years for a co-exclusive license to Landec's Intellicoat Seed Coating Technology.
- Supply Agreement: Monsanto agreed to pay $500,000 over five years for the manufacture and supply of polymer components.
- Merger Consideration: In a related merger, former Landec Ag shareholders received $5.62 per share, totaling approximately $7.3 million, plus a pro rata share of the earn-out.
- Financial Statements: Unaudited pro forma financial statements for the year ended May 28, 2006, and the quarter ended August 27, 2006, are included as Exhibit 99.2.
Material Changes and Strategic Shifts
Landec has exited its row-crop seed business, which included the Fielder's Choice Direct and Heartland Hybrids brands, by selling 100% of FCD Holding Company to Monsanto. Concurrently, the company has shifted focus toward its seed coating technology through a five-year agreement with Monsanto. The filing also notes a corporate restructuring where Landec Merger Corporation merged into Landec Ag, resulting in Landec Corporation owning 100% of Landec Ag.
Outlook, Risks, and Contingencies
- Call Option: Monsanto holds the right to purchase all outstanding shares of Landec Ag for an additional $8,000,000 at any time during the five-year license term.
- Termination Fee: If Monsanto terminates the license agreement early or fails to exercise the purchase option, it must pay a $4,000,000 termination fee, and technology rights revert to Landec.
- Non-Compete: Landec and Landec Ag are restricted from engaging in competing businesses in the U.S. or Canada for five years and cannot solicit FCD customers or employees.
- Tax Treatment: The transaction is structured as an asset sale under Section 338(h)(10) of the Internal Revenue Code.
Investor Verification Checklist
- Verify the pro forma financial impact of the $50 million cash inflow and the removal of the row-crop seed business operations.
- Review the specific gross margin targets required to trigger the $5 million earn-out payment.
- Assess the long-term revenue stability provided by the $12.5 million licensing deal versus the risk of early termination.
- Confirm the status of the $8 million call option held by Monsanto and the likelihood of its exercise.
- Examine the detailed terms of the non-compete and non-solicitation clauses to understand future growth limitations.